Our Products
Opsona Therapeutics is developing a number of highly innovative products to modulate the human immune system.

Our ability to deliver is reflected in our partnerships with global companies such as Wyeth/Pfizer and CSL and investors including GenenFUND and the Novartis and Roche Venture Funds.

Discover more about Opsona’s products.

Our Research

Our research is focused on using targeted approaches to explore the role of Toll-Like Receptors in innate immune pathways. 

A large body of recent ground breaking scientific research suggests that better understanding TLRs and TLR signalling, and applying this knowledge is an attractive, innovative approach to developing improved drugs for the treatment of autoimmune and inflammatory conditions, cancers and infectious diseases.

Read more about our research